Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,036,400
- Total 13F shares
- 81,682,735
- Share change
- +1,069,670
- Total reported value
- $58,794,209
- Price per share
- $0.72
- Number of holders
- 12
- Value change
- +$779,674
- Number of buys
- 4
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 98420P308?
CUSIP 98420P308 identifies XTNT - Xtant Medical Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420P308:
Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
52%
|
72,943,918
|
$37,894,000 | — | 30 Jun 2022 | |
| Matthew Rizzo |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,325,033
|
$10,552,677 | — | 15 Aug 2022 | |
| Michael Eggenberg |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,325,033
|
$10,552,677 | — | 15 Aug 2022 | |
| Altium Capital Management LLC |
13F
|
Company |
4.5%
|
6,246,291
|
$3,245,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.48%
|
670,900
|
$349,000 | — | 30 Jun 2022 | |
| Jeffrey J. Peters |
3/4/5
|
Director |
—
class O/S missing
|
448,546
|
$273,209 | — | 15 Aug 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
347,000
|
$180,000 | — | 30 Jun 2022 | |
| Greg Jensen |
3/4/5
|
Vice President, Finance & CFO |
—
mixed-class rows
|
477,639
mixed-class rows
|
$173,795 | — | 15 Aug 2021 | |
| Crescent Grove Advisors, LLC |
13F
|
Company |
0.19%
|
262,024
|
$136,000 | — | 30 Jun 2022 | |
| Midwest Professional Planners, LTD. |
13F
|
Company |
0.03%
|
40,744
|
$21,000 | — | 30 Jun 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
38,824
|
$20,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
23,666
|
$12,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
23,593
|
$12,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
10,926
|
$6,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
4,888
|
$3,000 | — | 30 Jun 2022 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
291
|
$151 | — | 30 Jun 2022 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q3 2022
As of 30 Sep 2022,
Xtant Medical Holdings, Inc. - Common Stock (XTNT) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,682,735 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Altium Capital Management LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Crescent Grove Advisors, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, CWM, LLC, Midwest Professional Planners, LTD., STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
12
Q3 2022 holders
12
Holder diff
0
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.